CVE-2018-14786

Name: CVE-2018-14786
Creator: NVD / NIST
Published: 2018-08-23T19:29:00.8+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

UnknownEPSS 3.06%

Last modified Jun 17, 2026

CVE-2018-14786 is a vulnerability of currently unknown severity. Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.. EPSS estimates a 3.06% chance of exploitation in the next 30 days.

Description

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

Metrics

EPSS Probability

3.06%

85.9th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

Vendor	Product	Versions
Bd	Alaris Gs Firmware	<= 2.3.6
Bd	Alaris Gh Firmware	<= 2.3.6
Bd	Alaris Cc Firmware	<= 2.3.6
Bd	Alaris Tiva Firmware	<= 2.3.6

References

http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-statesVendor Advisory
http://www.securityfocus.com/bid/105147Third Party Advisory, VDB Entry
https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01Third Party Advisory, US Government Resource
http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-statesVendor Advisory
http://www.securityfocus.com/bid/105147Third Party Advisory, VDB Entry
https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01Third Party Advisory, US Government Resource

Timeline

Published: Aug 23, 2018
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2018-14786?

How severe is CVE-2018-14786?

Severity scoring for CVE-2018-14786 is pending analysis. The EPSS model estimates a 3.06% probability of exploitation in the next 30 days.

How do I fix CVE-2018-14786?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2018-14786?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST